profile icon
Prof

Thomas Marwick

Interim Head Of Department
Baker Department Of Cardiometabolic Health
stress echocardiography
cardiac imaging
statistical modelling
Researcher/Clinic
economic analysis of cardiac imaging techniques
oncology
cross-specialty collaboration
early CV disease
diabetes
Thomas Marwick's Profile Picture
Prof

Thomas Marwick

 
Division
Medicine, Dentistry And Health Sciences
 
Primary Interest
Cardiology
Thomas Marwick's Profile Picture
Prof

Thomas Marwick

 

Professor Tom Marwick is the Baker Heart and Diabetes Institute Director and CEO, Cardiologist at the Alfred Hospital Melbourne and at Western Health in Melbourne. Professor Marwick is Associate Editor of the Journal of the American College of Cardiology (2014 - ) and JACC Imaging (2007 -).

Professor Marwick completed his training in medicine and cardiology in Australia, before undertaking an Imaging Fellowship at Cleveland Clinic, a PhD at the University of Louvain, Belgium and a Masters in Public Health at Harvard. He has divided his career mostly between Australia (former Professor of Medicine and Head of Cardiovascular Imaging Research Centre, UQ, and Director, Menzies Institute for Medical Research, University of Tasmania) and the USA (former Head of Cardiovascular Imaging at Cleveland Clinic). His main contribution has been in clinical research and research training, and has supervised about 30 research higher degree students – mainly clinical – including 22 completed PhDs. He has published about 700 papers, reviews, chapters and editorials, and is an Associate Editor at JACC and Deputy Editor at JACC-Cardiovascular Imaging. Tom has been the recipient of more than fifty significant research grants and several awards, including the Simon Dack Award from the American College of Cardiology (2009), the RT Hall Prize (2006), the Kempson Maddox Lecture (2011) of the Cardiac Society of Australia and New Zealand and the Bryant Stokes Oration (2016) of the Australian Academy of Health and Medical Sciences. Professor Marwick’s research has always sought to answer clinical questions - right from the very start of his career, when as a newly qualified doctor, he had early success in getting a paper on adrenalin use in cardiac arrest accepted by The Lancet. He was one of the initiators of stress echocardiography as a clinical tool, and has made contributions to the prognostic evidence underlying echocardiography. His main current research interests relate to the detection of early cardiovascular disease. Since developing expertise in quantitative analysis at the Harvard School of Public Health, his research has also included statistical modelling and economic analysis of cardiac imaging techniques for treatment selection and monitoring. In addition to informing policy and practice in cardiovascular testing, his work has involved cross-specialty collaboration, especially in oncology and diabetes. Heart failure is the forgotten complication of diabetes, and his work in Central Australia relates to early detection and intervention to prevent heart failure, which is becoming an important problem in the Aboriginal community.

Scholarly Works

Displaying the 1231 most recent scholarly works by Thomas Marwick.